


To maximise total return by investing in companies around the world with innovative products, processes or services, including those companies whose provision or use of technology gives them a strategic advantage in the market.
| Name | % Net Assets | 
|---|---|
| Oracle | 4.3% | 
| 4.1% | |
| Johnson & Johnson | 4.0% | 
| Cisco Systems | 3.8% | 
| Microsoft | 3.6% | 
| Astellas Pharma | 3.6% | 
| Amgen | 3.4% | 
| Schering-Plough | 3.4% | 
| Macdonald Dettwile | 3.3% | 
| Siemens | 2.9% | 
| Key | % Net Assets | 
|---|---|
| 4.3% | |
| 4.1% | |
| 4.0% | |
| 3.8% | |
| 83.8% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 04/10/1999 | 
|---|---|
| Fund Manager | Cyrille Filott | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | 10 | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | -0.06 | 
You are here: research